ADMA INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of ADMA Biologics, Inc. Investors – Holzer & Holzer, LLC Encourages Investors With Losses to Contact the Firm

ATLANTA, June 11, 2026 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed against ADMA Biologics, Inc. (“ADMA”) (NASDAQ: ADMA). The lawsuit alleges that Defendants made false and misleading statements and/or failed to disclose material adverse facts regarding ADMA’s business, operations, and prospects, including allegations that: (1) ADMA engaged in an undisclosed related party transaction; (2) ADMA used channel stuffing to create an appearance of revenue; and (3) ADMA lacked adequate internal controls.

If you purchased ADMA shares between August 9, 2024 and March 25, 2026, and experienced a loss on that investment, you are encouraged to discuss your legal rights by contacting Marshall P. Dees, Esq. at mdees@holzerlaw.com, by toll-free telephone at (888) 508-6832, or by visiting the firm’s website at www.holzerlaw.com/case/adma-biologics/ for more information.

The deadline to ask the court to be appointed lead plaintiff in the case is August 10, 2026.

Holzer & Holzer, LLC, an ISS top rated securities litigation law firm for 2021, 2022, 2023, and 2025, dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. Since its founding in 2000, Holzer & Holzer attorneys have played critical roles in recovering hundreds of millions of dollars for shareholders victimized by fraud and other corporate misconduct. More information about the firm is available through its website, www.holzerlaw.com, and upon request from the firm. Holzer & Holzer, LLC has paid for the dissemination of this promotional communication, and Corey Holzer is the attorney responsible for its content.

CONTACT:

Marshall P. Dees, Esq.

(888) 508-6832 (toll-free)

mdees@holzerlaw.com